Moderna Buys Biomanufacturing Site in Marlborough for $91M

Moderna Inc. has acquired a biomanufacturing site now under development in Marlborough from real estate giant Oxford Properties Group for $91 million.

The Cambridge-based vaccine maker plans to spend more than $300 million in building out the property, including by adding another 60,000 square feet to the 140,000-square-foot facility built by Oxford, according to a draft of a tax increment financing agreement between Moderna and Marlborough city officials.

More on this story from Boston Business Journal